Restoring mucosal barrier function and modifying macrophage phenotype with an extracellular matrix hydrogel: potential therapy for ulcerative colitisTools Keane, Timothy J., Dziki, Jenna, Sobieski, Eric, Smoulder, Adam, Castleton, Arthur A, Turner, Neill J., White, Lisa J. and Badylak, Stephen F. (2017) Restoring mucosal barrier function and modifying macrophage phenotype with an extracellular matrix hydrogel: potential therapy for ulcerative colitis. Journal of Crohn's and Colitis, 11 (3). 360 -368. ISSN 1873-9946 Full text not available from this repository.AbstractBackground & Aims: Despite advances in therapeutic options, more than half of all patients with ulcerative colitis (UC) do not achieve long-term remission, many require colectomy, and the disease still has a marked negative impact on quality of life. Extracellular matrix (ECM) bioscaffolds facilitate the functional repair of many soft tissues by mechanisms that include mitigation of pro-inflammatory macrophage phenotype and mobilization of endogenous stem/progenitor cells. The aim of the present study was to determine if an ECM hydrogel therapy could influence outcomes in an inducible rodent model of UC.
Actions (Archive Staff Only)
|